Testing for the genetic anomaly TMPRSS2:ERG in conjunction with use prostate cancer antigen 3 (PCA3) is better at predicting the presence of prostate cancer (PCa) than either marker alone, according ...

PSA blood test A study of 400,887 men in an integrated health system, the first to evaluate various PSA screening intervals and age groups, concluded that yearly screening is the interval of choice.

Real-world (RW) prevalence of adverse events (AEs) among patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC). Outcomes in a theoretical cohort of 100,000 female FDRs of men ...

Transitional care management for cancer patients: Extending general models of population health management to an oncology specific population. The use of an electronic medical record (EMR) best ...